Jennifer Heimall, MD

Papers

2022

Rychik J, Goldberg DJ, Rand E, Mancilla EE, Heimall J, Seivert N, Campbell D, O'Malley S, Dodds KM. A Path FORWARD: Development of a Comprehensive Multidisciplinary Clinic to Create Health and Wellness for the Child and Adolescent with a Fontan Circulation. Pediatr Cardiol. 2022 Aug;43(6):1175-1192. doi: 10.1007/s00246-022-02930-z. Epub 2022 May 23.PMID: 35604474

Cuvelier GDE, Logan BR, Prockop S, Buckley RH, Kuo CY, Griffith LM, Liu X, Yip A, Hershfield M, Ayoub P, Moore TB, Dorsey M, O'Reilly RJ, Kapoor N, Pai SY, Kapadia M, Ebens CL, Forbes Satter LR, Burroughs L, Petrovic A, Chellapandian D, Heimall J, Shyr D, Rayes A, Bednarski JJ, Chandra S, Chandrakasan S, Gilio AP, Madden LM, Quigg TC, Caywood EH, Dávila Saldaña BJ, DeSantes K, Eissa H, Goldman FD, Rozmus J, Shah A, Vander Lugt MT, Thakar MS, Parrott RE, Martinez CA, Leiding JW, Torgerson TR, Pulsipher MA, Notarangelo LD, Cowan MJ, Dvorak CC, Haddad E, Puck JM, Kohn DB. Outcomes Following Treatment for Adenosine Deaminase Deficient Severe Combined Immunodeficiency: A Report from the PIDTC. Blood. 2022 Jun 7:blood.2022016196. doi: 10.1182/blood.2022016196. Online ahead of print.PMID: 35671392

Arnold DE, Chellapandian D, Parikh S, Mallhi K, Marsh RA, Heimall JR, Grossman D, Chitty-Lopez M, Murguia-Favela L, Gennery AR, Boulad F, Arbuckle E, Cowan MJ, Dvorak CC, Griffith LM, Haddad E, Kohn DB, Notarangelo LD, Pai SY, Puck JM, Pulsipher MA, Torgerson T, Kang EM, Malech HL, Leiding JW Granulocyte Transfusions in Patients with Chronic Granulomatous Disease Undergoing Hematopoietic Cell Transplantation or Gene Therapy. .J Clin Immunol. 2022 Apr 21:1-10. doi: 10.1007/s10875-022-01261-1. Online ahead of print.PMID: 35445907

Sun D, Heimall JR, Greenhawt MJ, Bunin NJ, Shaker MS, Romberg N. Cost Utility of Lifelong Immunoglobulin Replacement Therapy vs Hematopoietic Stem Cell Transplant to Treat Agammaglobulinemia. JAMA Pediatr. 2022 Feb 1;176(2):176-184. doi: 10.1001/jamapediatrics.2021.4583.PMID: 34779842

Arnold DE, Nofal R, Wakefield C, Lehmberg K, Wustrau K, Albert MH, Morris EC, Heimall JR, Bunin NJ, Kumar A, Jordan MB, Cole T, Choo S, Brettig T, Speckmann C, Ehl S, Salamonowicz M, Wahlstrom J, Rao K, Booth C, Worth A, Marsh RA. Reduced-Intensity/Reduced-Toxicity Conditioning Approaches Are Tolerated in XIAP Deficiency but Patients Fare Poorly with Acute GVHD. J Clin Immunol. 2022 Jan;42(1):36-45. doi: 10.1007/s10875-021-01103-6. Epub 2021 Sep 29.PMID: 34586554

Magg T, Okano T, Koenig LM, Boehmer DFR, Schwartz SL, Inoue K, Heimall J, Licciardi F, Ley-Zaporozhan J, Ferdman RM, Caballero-Oteyza A, Park EN, Calderon BM, Dey D, Kanegane H, Cho K, Montin D, Reiter K, Griese M, Albert MH, Rohlfs M, Gray P, Walz C, Conn GL, Sullivan KE, Klein C, Morio T, Hauck F. Heterozygous OAS1 gain-of-function variants cause an autoinflammatory immunodeficiency. Sci Immunol. 2021 Jun 18;6(60):eabf9564. doi: 10.1126/sciimmunol.abf9564.PMID: 34145065

2021

Smith H, Scalchunes C, Cowan MJ, Puck J, Heimall J. Expectations and experience: Parent and patient perspectives regarding treatment for Severe Combined Immunodeficiency (SCID). Clin Immunol. 2021 Jun 16;229:108778. doi: 10.1016/j.clim.2021.108778. Online ahead of print.PMID: 34144198

Crowley TB, Campbell IM, Liebling EJ, Lambert MP, Levitt Katz LE, Heimall J, Bailey A, McGinn DE, McDonald McGinn DM, Sullivan KE. Distinct immune trajectories in patients with chromosome 22q11.2 deletion syndrome and immune-mediated diseases. J Allergy Clin Immunol. 2021 Jun 16:S0091-6749(21)00939-8. doi: 10.1016/j.jaci.2021.06.007. Online ahead of print.PMID: 34144109

Egg D, Rump IC, Mitsuiki N, Rojas-Restrepo J, Maccari ME, Schwab C, Gabrysch A, Warnatz K, Goldacker S, Patiño V, Wolff D, Okada S, Hayakawa S, Shikama Y, Kanda K, Imai K, Sotomatsu M, Kuwashima M, Kamiya T, Morio T, Matsumoto K, Mori T, Yoshimoto Y, Dybedal I, Kanariou M, Kucuk ZY, Chapdelaine H, Petruzelkova L, Lorenz HM, Sullivan KE, Heimall J, Moutschen M, Litzman J, Recher M, Albert MH, Hauck F, Seneviratne S, Pachlopnik Schmid J, Kolios A, Unglik G, Klemann C, Snapper S, Giulino-Roth L, Svaton M, Platt CD, Hambleton S, Neth O, Gosse G, Reinsch S, Holzinger D, Kim YJ, Bakhtiar S, Atschekzei F, Schmidt R, Sogkas G, Chandrakasan S, Rae W, Derfalvi B, Marquart HV, Ozen A, Kiykim A, Karakoc-Aydiner E, Králíčková P, de Bree G, Kiritsi D, Seidel MG, Kobbe R, Dantzer J, Alsina L, Armangue T, Lougaris V, Agyeman P, Nyström S, Buchbinder D, Arkwright PD, Grimbacher B. Therapeutic options for CTLA-4 insufficiency. J Allergy Clin Immunol. 2021 Jun 7:S0091-6749(21)00891-5. doi: 10.1016/j.jaci.2021.04.039. PMID: 34111452

Patel T, Henrickson SE, Moser EK, Field NS, Maurer K, Dawany N, Conrad M, Bunin N, Freedman JL, Heimall J, Arnold DE, Wang J, Markowitz JE, Payne-Poff SB, Williams KW, Russo PA, Wherry EJ, Devoto M, Oliver P, Sullivan KE, Kelsen JR. Immune Dysregulation in Human ITCH Deficiency Successfully Treated with Hematopoietic Cell Transplantation. J Allergy Clin Immunol Pract. 2021 Jul;9(7):2885-2893.e3. doi: 10.1016/j.jaip.2021.04.010. PMID: 33894394

Mancilla EE, Zielonka B, Roizen JD, Dodds KM, Rand EB, Heimall JR, Chen F, Wu C, Goldberg DJ, Rychik J.  Growth in Children with a Fontan Circulation. J Pediatr. 2021 Apr 19:S0022-3476(21)00345-0. doi: 10.1016/j.jpeds.2021.04.019. Online ahead of print.PMID: 33887332

Arnold DE, MacMath D, Seif AE, Heimall JR, Wang Y, Monos D, Grupp SA, Bunin NJ. Immune Reconstitution Following TCRαβ/CD19-Depleted Hematopoietic Cell Transplantation for Hematologic Malignancy in Pediatric Patients.Transplant Cell Ther. 2021 Feb;27(2):169.e1-169.e9. doi: 10.1016/j.jtct.2020.10.006. Epub 2020 Dec 10.PMID: 33830028

Harrison SC, Tsilifis C, Slatter MA, Nademi Z, Worth A, Veys P, Ponsford MJ, Jolles S, Al-Herz W, Flood T, Cant AJ, Doffinger R, Barcenas-Morales G, Carpenter B, Hough R, Haraldsson Á, Heimall J, Grimbacher B, Abinun M, Gennery AR. “Hematopoietic Stem Cell Transplantation Resolves the Immune Deficit Associated with STAT3-Dominant-Negative Hyper-IgE Syndrome.”  J Clin Immunol. 2021 Feb 1. doi: 10.1007/s10875-021-00971-2. Online ahead of print. PMID: 33523338

2020

Weinreb SJ, Dodds KM, Burstein DS, Huang J, Rand EB, Mancilla E, Heimall JR, McBride MG, Paridon SM, Goldberg DJ, Rychik J. “End-Organ Function and Exercise Performance in Patients With Fontan Circulation: What Characterizes the High Performers?” J Am Heart Assoc. 2020 Dec 15;9(24):e016850. doi: 10.1161/JAHA.120.016850. Epub 2020 Dec 2. PMID: 33317366

Knight V, Heimall JR, Wright N, Dutmer CM, Boyce TG, Torgerson TR, Abraham RS. “Follow-Up for an Abnormal Newborn Screen for Severe Combined Immunodeficiencies (NBS SCID): A Clinical Immunology Society (CIS) Survey of Current Practices.” Int J Neonatal Screen. 2020 Jun 30;6(3):52. doi: 10.3390/ijns6030052. PMID: 33239578

Dorsey MJ, Wright NAM, Chaimowitz NS, Dávila Saldaña BJ, Miller H, Keller MD, Thakar MS, Shah AJ, Abu-Arja R, Andolina J, Aquino V, Barnum JL, Bednarski JJ, Bhatia M, Bonilla FA, Butte MJ, Bunin NJ, Chandra S, Chaudhury S, Chen K, Chong H, Cuvelier GDE, Dalal J, DeFelice ML, DeSantes KB, Forbes LR, Gillio A, Goldman F, Joshi AY, Kapoor N, Knutsen AP, Kobrynski L, Lieberman JA, Leiding JW, Oshrine B, Patel KP, Prockop S, Quigg TC, Quinones R, Schultz KR, Seroogy C, Shyr D, Siegel S, Smith AR, Torgerson TR, Vander Lugt MT, Yu LC, Cowan MJ, Buckley RH, Dvorak CC, Griffith LM, Haddad E, Kohn DB, Logan B, Notarangelo LD, Pai SY, Puck J, Pulsipher MA, Heimall J. Infections in Infants with SCID: Isolation, Infection Screening, and Prophylaxis in PIDTC Centers.  J Clin Immunol. 2020 Oct 2. doi: 10.1007/s10875-020-00865-9. Online ahead of print. PMID: 33006109

Sun D, Lee J, Heimall J, Jyonouchi S. Immunodeficiency in 22q11.2 duplication syndrome. J Allergy Clin Immunol Pract. 2020 Sep 16:S2213-2198(20)30951-X. doi: 10.1016/j.jaip.2020.09.005. Online ahead of print. PMID: 32949807

Sun D, Heimall J. “Geographical distribution of allergy/immunology providers in the United States and association with median income.” J Allergy Clin Immunol Pract. 2020 Sep;8(8):2802-2804. PMID: 32334079

Chan AY, Leiding JW, Liu X, Logan BR, Burroughs LM, Allenspach EJ, Skoda-Smith S, Uzel G, Notarangelo LD, Slatter M, Gennery AR, Smith AR, Pai SY, Jordan MB, Marsh RA, Cowan MJ, Dvorak CC, Craddock JA, Prockop SE, Chandrakasan S, Kapoor N, Buckley RH, Parikh S, Chellapandian D, Oshrine BR, Bednarski JJ, Cooper MA, Shenoy S, Davila Saldana BJ, Forbes LR, Martinez C, Haddad E, Shyr DC, Chen K, Sullivan KE, Heimall J, Wright N, Bhatia M, Cuvelier GDE, Goldman FD, Meyts I, Miller HK, Seidel MG, Vander Lugt MT, Bacchetta R, Weinacht KG, Andolina JR, Caywood E, Chong H, de la Morena MT, Aquino VM, Shereck E, Walter JE, Dorsey MJ, Seroogy CM, Griffith LM, Kohn DB, Puck JM, Pulsipher MA, Torgerson TR. “Hematopoietic Cell Transplantation in Patients With Primary Immune Regulatory Disorders (PIRD): A Primary Immune Deficiency Treatment Consortium (PIDTC) Survey.” Front Immunol. 2020 Feb 21;11:239. PMID: 32153572

Arnold DE, Maude SL, Callahan CA, DiNofia AM, Grupp SA, Heimall JR. “Subcutaneous immunoglobulin replacement following CD19-specific chimeric antigen receptor T-cell therapy for B-cell acute lymphoblastic leukemia in pediatric patients.” Pediatr Blood Cancer. 2020 Mar;67(3):e28092. doi: 10.1002/pbc.28092. PMID: 31793170

2019

Bosticardo M, Yamazaki Y, Cowan J, Giardino G, Corsino C, Scalia G, Prencipe R, Ruffner M, Hill DA, Sakovich I, Yemialyanava I, Tam JS, Padem N, Elder ME, Sleasman JW, Perez E, Niebur H, Seroogy CM, Sharapova S, Gebbia J, Kleiner GI, Peake J, Abbott JK, Gelfand EW, Crestani E, Biggs C, Butte MJ, Hartog N, Hayward A, Chen K, Heimall J, Seeborg F, Bartnikas LM, Cooper MA, Pignata C, Bhandoola A, Notarangelo LD. “Heterozygous FOXN1 Variants Cause Low TRECs and Severe T Cell Lymphopenia, Revealing a Crucial Role of FOXN1 in Supporting Early Thymopoiesis.” Am J Hum Genet. 2019 Sep 5;105(3):549-561. PMID: 31447097

Le Coz C, Bengsch B, Khanna C, Trofa M, Ohtani T, Nolan BE, Henrickson SE, Lambert MP, Kim TO, Despotovic JM, Feldman S, Fadugba OO, Takach P, Ruffner M, Jyonouchi S, Heimall J, Sullivan KE, Wherry EJ, Romberg N. “Common variable immunodeficiency-associated endotoxemia promotes early commitment to the T follicular lineage.” J Allergy Clin Immunol. 2019 Dec;144(6):1660-1673. PMID: 31445098

Marsh RA, Leiding JW, Logan BR, Griffith LM, Arnold DE, Haddad E, Falcone EL, Yin Z, Patel K, Arbuckle E, Bleesing JJ, Sullivan KE, Heimall J, Burroughs LM, Skoda-Smith S, Chandrakasan S, Yu LC, Oshrine BR, Cuvelier GDE, Thakar MS, Chen K, Teira P, Shenoy S, Phelan R, Forbes LR, Chellapandian D, Dávila Saldaña BJ, Shah AJ, Weinacht KG, Joshi A, Boulad F, Quigg TC, Dvorak CC, Grossman D, Torgerson T, Graham P, Prasad V, Knutsen A, Chong H, Miller H, de la Morena MT, DeSantes K, Cowan MJ, Notarangelo LD, Kohn DB, Stenger E, Pai SY, Routes JM, Puck JM, Kapoor N, Pulsipher MA, Malech HL, Parikh S, Kang EM; submitted on behalf of the Primary Immune Deficiency Treatment Consortium. “Chronic Granulomatous Disease-Associated IBD Resolves and Does Not Adversely Impact Survival Following Allogeneic HCT.” J Clin Immunol. 2019 Oct;39(7):653-667. PMID: 31376032

Keller MD, Darko S, Lang H, Ransier A, Lazarski CA, Wang Y, Hanley PJ, Davila BJ, Heimall JR, Ambinder RF, Barrett AJ, Rooney CM, Heslop HE, Douek DC, Bollard CM. “T-cell receptor sequencing demonstrates persistence of virus-specific T cells after antiviral immunotherapy.” Br J Haematol. 2019 Oct;187(2):206-218.. PMID: 31219185

Henrickson SE, Andre-Schmutz I, Lagresle-Peyrou C, Deardorff MA, Jyonouchi H, Neven B, Bunin N, Heimall JR. “Hematopoietic Stem Cell Transplant for the Treatment of X-MAID.” Front Pediatr. 2019 May 14;7:170 PMID: 31139601

Arnold DE, Seif AE, Jyonouchi S, Sullivan KE, Bunin NJ, Heimall JR. “Allogeneic hematopoietic stem cell transplantation in adolescent patients with chronic granulomatous disease.” J Allergy Clin Immunol Pract. 2019 Mar;7(3):1052-1054.e2.. PMID: 30391552

Wang KY, Lee J, Cianferoni A, Ruffner MA, Dean A, Molleston JM, Pawlowski NA, Heimall J, Saltzman RW, Ram GS, Fiedler J, Gober LM, Spergel JM, Brown-Whitehorn TF. “Food Protein-Induced Enterocolitis Syndrome Food Challenges: Experience from a Large Referral Center.” J Allergy Clin Immunol Pract. 2019 Feb;7(2):444-450. PMID: 30243880

Dvorak CC, Haddad E, Buckley RH, Cowan MJ, Logan B, Griffith LM, Kohn DB, Pai SY, Notarangelo L, Shearer W, Prockop S, Kapoor N, Heimall J, Chaudhury S, Shyr D, Chandra S, Cuvelier G, Moore T, Shenoy S, Goldman F, Smith AR, Sunkersett G, Vander Lugt M, Caywood E, Quigg T, Torgerson T, Chandrakasan S, Craddock J, Dávila Saldaña BJ, Gillio A, Shereck E, Aquino V, DeSantes K, Knutsen A, Thakar M, Yu L, Puck JM. “The genetic landscape of severe combined immunodeficiency in the United States and Canada in the current era (2010-2018)”. J Allergy Clin Immunol. 2019 Jan;143(1):405-407. PMID: 30193840

2018

Arnold DE, Seif AE, Jyonouchi S, Sullivan KE, Bunin NJ, Heimall JR. Allogeneic Hematopoietic Stem Cell Transplantation in Adolescent Patients with Chronic Granulomatous Disease. J Allergy Clin Immunol Pract. 2018 Nov 1. pii: S2213-2198(18)30705-0. doi: 10.1016/j.jaip.2018.10.034. [Epub ahead of print] PMID: 30391552

Kennedy K, Heimall J, Spergel JM. Advances in Atopic Dermatitis in 2017. J Allergy Clin Immunol. 2018 Oct 22. pii: S0091-6749(18)31480-5. doi: 10.1016/j.jaci.2018.10.012. [Epub ahead of print] PMID: 30359683

Bird JA, Spergel JM, Jones SM, Rachid R, Assa'ad AH, Wang J, et al. Efficacy and Safety of AR101 in Oral Immunotherapy for Peanut Allergy: Results of ARC001, a Randomized, Double-Blind, Placebo-Controlled Phase 2 Clinical Trial. J Allergy Clin Immunol Pract. 2018 Mar - Apr;6(2):476-485.e3. doi: 10.1016/j.jaip.2017.09.016. Epub 2017 Oct 31. PMID: 29092786

Wang KY, Lee J, Cianferoni A, Ruffner MA, Dean A, Heimall J, et al. Food Protein-Induced Enterocolitis Syndrome Food Challenges: Experience from a Large Referral Center. J Allergy Clin Immunol Pract. 2018 Sep 20. pii: S2213-2198(18)30585-3. doi: 10.1016/j.jaip.2018.09.009. [Epub ahead of print] PMID: 30243880

Dvorak CC, Haddad E, Buckley RH, Cowan MJ, Logan B, Heimall J, et al. The genetic landscape of severe combined immunodeficiency in the United States and Canada in the current era (2010-2018). J Allergy Clin Immunol. 2018 Sep 5. pii: S0091-6749(18)31271-5. doi: 10.1016/j.jaci.2018.08.027. [Epub ahead of print] PMID: 30193840

Haddad E, Logan BR, Griffith LM, Buckley RH, Parrott RE, Heimall J, et al. SCID genotype and 6-month posttransplant CD4 count predict survival and immune recovery. Blood. 2018 Oct 25;132(17):1737-1749. doi: 10.1182/blood-2018-03-840702. Epub 2018 Aug 28. PMID: 30154114

Capucilli P, Cianferoni A, Fiedler J, Gober L, Pawlowski N, Heimall J, et al. Differences in egg and milk food challenge outcomes based on tolerance to the baked form. Ann Allergy Asthma Immunol. 2018 Nov;121(5):580-587. doi: 10.1016/j.anai.2018.07.018. Epub 2018 Jul 21. PMID: 30036581

Romberg N, Le Coz C, Glauzy S, Schickel JN, Trofa M, Heimall J, et al. Patients with common variable immunodeficiency with autoimmune cytopenias exhibit hyperplastic yet inefficient germinal center responses. J Allergy Clin Immunol. 2018 Jun 20. pii: S0091-6749(18)30897-2. doi: 10.1016/j.jaci.2018.06.012. [Epub ahead of print] PMID: 29935219

Heimall JR, Hagin D, Hajjar J, Henrickson SE, Hernandez-Trujillo HS, Tan Y, et al. Use of Genetic Testing for Primary Immunodeficiency Patients. J Clin Immunol. 2018 Apr;38(3):320-329. doi: 10.1007/s10875-018-0489-8. Epub 2018 Apr 19. Erratum in: J Clin Immunol. 2018 May 21. PMID: 29675737

2017

Arnold DE, Heimall JR. A Review of Chronic Granulomatous Disease. Adv Ther. 2017 Dec;34(12):2543-2557. doi: 10.1007/s12325-017-0636-2. Epub 2017 Nov 22. Review. PMID: 29168144

Heimall J, Logan BR, Cowan MJ, Notarangelo LD, Griffith LM, Puck JM, et al. Immune reconstitution and survival of 100 SCID patients post-hematopoietic cell transplant: a PIDTC natural history study. Blood. 2017 Dec 21;130(25):2718-2727. doi: 10.1182/blood-2017-05-781849. Epub 2017 Oct 11. PMID: 29021228

Heimall J, Cowan MJ. Long term outcomes of severe combined immunodeficiency: therapy implications. Expert Rev Clin Immunol. 2017 Nov;13(11):1029-1040. doi: 10.1080/1744666X.2017.1381558. Epub 2017 Sep 23. Review. PMID: 28918671

Arora M, Bagi P, Strongin A, Heimall J, Zhao X, Lawrence MG, et al. Gastrointestinal Manifestations of STAT3-Deficient Hyper-IgE Syndrome. J Clin Immunol. 2017 Oct;37(7):695-700. doi: 10.1007/s10875-017-0429-z. Epub 2017 Aug 13. PMID: 28803389

Heimall J, Spergel JM. New pathways for itching in patients with atopic dermatitis? J Allergy Clin Immunol. 2017 Aug;140(2):393-394. doi: 10.1016/j.jaci.2017.06.004. Epub 2017 Jun 23. PMID: 28652154

Barry JC, Crowley TB, Jyonouchi S, Heimall J, Zackai EH, Sullivan KE, McDonald-McGinn DM. Identification of 22q11.2 Deletion Syndrome via Newborn Screening for Severe Combined Immunodeficiency. J Clin Immunol. 2017 Jul;37(5):476-485. doi: 10.1007/s10875-017-0403-9. Epub 2017 May 24. PMID: 28540525

2016

MacGinnitie AJ, Rachid R, Gragg H, Little SV, Lakin P, Cianferoni A, et al. Omalizumab facilitates rapid oral desensitization for peanut allergy. J Allergy Clin Immunol. 2017 Mar;139(3):873-881.e8. doi: 10.1016/j.jaci.2016.08.010. Epub 2016 Sep 5. PMID: 27609658

Kamoun C, Morsheimer M, Sullivan KE, Holland SM, Rundles CC, Bunin N, Heimall JR. Successful unrelated cord blood transplant for complete IFN-γ receptor 2 deficiency. J Allergy Clin Immunol. 2016 Nov;138(5):1489-1491. doi: 10.1016/j.jaci.2016.06.017. Epub 2016 Jul 14. PMID: 27522156

Heimall J, Chen J, Church JA, Griffin R, Melamed I, Kleiner GI. Pharmacokinetics, Safety, and Tolerability of Subcutaneous Immune Globulin Injection (Human), 10 % Caprylate/Chromatography Purified (GAMUNEX®-C) in Pediatric Patients with Primary Immunodeficiency Disease. J Clin Immunol. 2016 Aug;36(6):600-9. doi: 10.1007/s10875-016-0311-4. Epub 2016 Jun 25. PMID: 27342758

Keller MD, Pandey R, Li D, Glessner J, Tian L, Heimall J, et al. Mutation in IRF2BP2 is responsible for a familial form of common variable immunodeficiency disorder. J Allergy Clin Immunol. 2016 Aug;138(2):544-550.e4. doi: 10.1016/j.jaci.2016.01.018. Epub 2016 Mar 23. PMID: 27016798

Naik S, Nicholas SK, Martinez CA, Leen AM, Hanley PJ, Heimall J, et al. Adoptive immunotherapy for primary immunodeficiency disorders with virus-specific T lymphocytes. J Allergy Clin Immunol. 2016 May;137(5):1498-1505.e1. doi: 10.1016/j.jaci.2015.12.1311. Epub 2016 Feb 24. PMID: 26920464

Morsheimer MM, Rychik J, Forbes L, Dodds K, Goldberg DJ, Sullivan K, Heimall JR. Risk Factors and Clinical Significance of Lymphopenia in Survivors of the Fontan Procedure for Single-Ventricle Congenital Cardiac Disease. J Allergy Clin Immunol Pract. 2016 May-Jun;4(3):491-6. doi: 10.1016/j.jaip.2015.11.034. Epub 2016 Feb 18. PMID: 26897303

2015

Patel NC, Gallagher JL, Ochs HD, Prescott Atkinson T, Wahlstrom J, Heimall J, et al. Subcutaneous Immunoglobulin Replacement Therapy with Hizentra® is Safe and Effective in Children Less Than 5 Years of Age. J Clin Immunol. 2015 Aug;35(6):558-65. doi: 10.1007/s10875-015-0190-0. Epub 2015 Sep 4. PMID: 26336818

Oshrine B, Morsheimer M, Heimall J, Bunin N. Reduced-intensity conditioning for hematopoietic cell transplantation of chronic granulomatous disease. Pediatr Blood Cancer. 2015 Feb;62(2):359-361. doi: 10.1002/pbc.25225. Epub 2014 Aug 30. PMID: 25175046

Gupta M, Sindher S, Saltzman R, Heimall J. Evaluation and subsequent safe administration of rabies vaccine to a child presumably allergic to the gelatin content of PCECV Rabavert. J Allergy Clin Immunol Pract. 2015 Mar-Apr;3(2):281-2. doi: 10.1016/j.jaip.2014.10.005. Epub 2014 Nov 18. PMID: 25609331

2014

Privette ED, Ram G, Treat JR, Yan AC, Heimall JR. Healing of granulomatous skin changes in ataxia-telangiectasia after treatment with intravenous immunoglobulin and topical mometasone 0.1% ointment. Pediatr Dermatol. 2014 Nov-Dec;31(6):703-7. doi: 10.1111/pde.12411. Epub 2014 Sep 18. PMID: 25236668

Griffith LM, Cowan MJ, Notarangelo LD, Kohn DB, Puck JM, Heimall JR, et al. Primary Immune Deficiency Treatment Consortium (PIDTC) report. J Allergy Clin Immunol. 2014 Feb;133(2):335-47. doi: 10.1016/j.jaci.2013.07.052. Epub 2013 Oct 15. PMID: 24139498

2011

Sekhsaria V, Dodd LE, Hsu AP, Hemall JR, Freeman AF, Ding L, et al. Plasma metalloproteinase levels are dysregulated in signal transducer and activator of transcription 3 mutated hyper-IgE syndrome. J Allergy Clin Immunol. 2011 Nov;128(5);1124-7. Epub 2011 Aug 27. Cited in PubMed; PMID 21872914. No abstract available.

Heimall J, Davis J, Shaw P, Hsu A, Gu W, Welch P, et al. Paucity of genotype-phenotype correlations in STAT3 mutated hyper IgE syndrome (HIES) patients. Clin Immunol. 2011 Apr;139(1):75-84. Epub 2011 Jan 14. Cited in PubMed; PMID 21288777.

Hemall J, Freeman A, Holland SM. Pathogenesis of hyper IgE syndrome. Clin Rev Allergy Immunol. 2010 Feb;38(1):32-8. Review. Cited in PubMed; PMID 19452285.

Books

Heimall J. IDF Patient and Family Handbook for Primary Immunodeficiency Diseases, 6th Edition; 2018-2019 Editorial Board, published January 2020

Chapters

2020

Yu JE, Heimall J. “Protein and Lymphatic Loss Conditions”. Stiehm’s Immune Deficiencies, 2nd Edition, 2020, Ch 50

Buckley R, Heimall J. “Classic Severe Combined Immunodeficiency”. IDF Patient and Family Handbook for Primary Immunodeficiency Diseases, 6th Edition; 2020, Ch8

Freeman A, Heimall J. “Hyper IgE Syndromes (HIES): STAT3 Loss of Function, DOCK8 Deficiency and Others”. IDF Patient and Family Handbook for Primary Immunodeficiency Diseases, 6th Edition; 2020, Ch 20

2017

Heimall J, Sullivan KE “Defects of Innate Immunity”. Nelson’s Pediatrics 2017 Chapter 152.3

2008

Heimall J, Bielory L. Complementary and alternative medicine in the treatment of allergic and asthmatic disease. In: Mahmoudi M, editor. Allergy and asthma practical diagnosis and management. New York: McGraw Hill Medical; 2008.

Posters and Presentations

Invited Lectures

2022

Heimall J. “Minding the Gap between a SCID diagnosis and definitive treatment: What can be done to keep the baby safe” SCID Family Day, IDF Compass Program and Clinic for Special Children, Strasburg, PA. July 2022.

Heimall J. “IgG management and integration of immunomodulation with IgG replacement therapy”; “This is a team sport: Medical networking and partnering to facilitate coordinated patient-centered care”, CIS AIM Program, Boston, MA. June 2022.

Heimall J. “Early Career Immunologist Career Development Panel, Representing Program Leadership” CIS Annual Meeting, Charlotte, NC. April 2022.

Heimall J. “Immunologically Medicated Skin Diseases” AAAAI Board Review Course, Virtual Presentation. March 2022.

Heimall J. “Pro/Con Debate: 2552 Genetic Testing for All: Putting the Cart Before the Horse? Functional Testing First”, “What to do with an Abnormal Newborn Screen”, “3703 BCI: Prevention and Treatment of COVID-19 in Patients with Primary Immune Deficiency Disease (PIDD)” AAAAI Annual Meeting, Pheoniz, AZ. Feb 2022.

2021

Heimall J. “The Ultimate Targeted Therapy: BMT for Patients with Monogenic VEO-IBD and Beyond” and Panel discussion speaker. Personalized IBD and VEO-IBD: Genomics, Microbiome, Biologics and Beyond Educational Symposium, Philadelphia, PA. Oct 2021.

Heimall J. “SCID Education Session: Post -Transplant Late Effects in Patients with SCID ” Immune Deficiency Foundation 2021 Rare of the Rare Conference, Virtual Presentation. Oct 2021.

Heimall J. “When to Refer Young Adult Patients to an Immunologist” Immune Deficiency Foundation 2021 Primary immunodeficiency Conference, Virtual Presentation. June 2021.

Heimall J. “Functional Asplenia: Clinical Immunologist Perspective” Expert Commentary to COG LTFU Guidelines Task Force, Virtual Presentation. March 2021.

Heimall J. “Session 3004: When Low T Cell Receptor Excision Circles Don’t Equal Severe Combined Immunodeficiency: Idiopathic T Lymphopenia and More” AAAAI Annual Meeting, Virtual Presentation. Feb 2021.

2020

Heimall J. “Neutropenia as a sign of inborn error of Immunity”  NICER Webinar, Senior Mentor. Dec 2020.

Heimall J. “Neutropenia as a sign of inborn error of Immunity”  NICER Webinar, Senior Mentor. Nov 2020.

Heimall J. “Immunologically Medicated Skin Diseases” AAAAI Board Review Course, Virtual Presentation. May 2020.

Heimall J. “Organ System Abnormalities in patients with SCID after HSCT” PIDTC 10th Annual Scientific Meeting, Virtual Presentation. Apr 2020.

Heimall J. “Primary Immunodeficiency Overview”, “Primary Immune Regulatory Disorders”, “Combined Immunodeficiency”, “Humoral Immunodeficiency” Lectures given as part of the faculty for the Open Medical Institute- CHOP Pediatric Allergy and Immunology Seminar, Salzburg, Austria. Feb 2020.